Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease

Diabetic kidney disease (DKD) is a chronic inflammatory condition that affects approximately 20-40% of individuals with diabetes. Sodium-glucose co-transporter 2 (SGLT-2) inhibitors, emerging as novel hypoglycemic agents, have demonstrated significant cardiorenal protective effects in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Zhi-Cheng, Chen, Jin-Xia, Zou, Rong, Liang, Xuan-Bing, Tang, Ji-Xin, Yao, Cui-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552262/
https://www.ncbi.nlm.nih.gov/pubmed/37809091
http://dx.doi.org/10.3389/fimmu.2023.1213473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552262/
https://www.ncbi.nlm.nih.gov/pubmed/37809091
http://dx.doi.org/10.3389/fimmu.2023.1213473

Ejemplares similares